The Best of Hematology and Breast Cancer 2025 conference in San Diego is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

The Central Illinois Hematology Oncology Conference is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology.

The Best of Hematology and Breast Cancer 2025 conference in Coeur d'Alene is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

The Best of Hematology and Breast Cancer 2025 conference in Boise is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

This accredited continuing education activity “2024 Seattle Cellular Therapy Summit: Updates & Focus on Accessibility ”, is recorded from the live conference held from 8/16/2024 to 8/17/2024. 

The Best of Hematology and Breast Cancer 2025 conference in Des Moines is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

The Best of Hematology and Breast Cancer 2025 conference in Augusta is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

The Best of Hematology 2025 conference in Albuquerque is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology.

The Best of Hematology and Breast Cancer 2025 conference in Houston is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.

The Best of Hematology and Breast Cancer 2025 conference in Portland is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer.